Ubs Group Ag Nephros Inc Transaction History

Ubs Group Ag

$397 Billion
Q1 2024

A detailed history of Ubs Group Ag transactions in Nephros Inc stock. As of the latest transaction made, Ubs Group Ag holds 307 shares of NEPH stock, worth $647. This represents 0.0% of its overall portfolio holdings.

Number of Shares

307

Previous 11 2690.91%

Holding current value

$647

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$2.11 - $3.78 $624 - $1,118	296 Added 2690.91%	307 $0
Q2 2023 Aug 11, 2023	SELL	$1.14 - $2.02 $257 - $456	-226 Reduced 95.36%	11 $0
Q1 2023 May 12, 2023	SELL	$0.97 - $1.35 $9,985 - $13,896	-10,294 Reduced 97.75%	237 $0
Q4 2022 Feb 08, 2023	SELL	$0.99 - $1.25 $1,329 - $1,678	-1,343 Reduced 11.31%	10,531 $12,000
Q3 2022 Nov 10, 2022	BUY	$0.97 - $1.87 $11,007 - $21,220	11,348 Added 2157.41%	11,874 $11,000

Q2 2022 Aug 10, 2022	BUY	$1.47 - $4.63 $757 - $2,384	515 Added 4681.82%	526 $1,000
Q3 2021 Nov 15, 2021	SELL	$7.6 - $10.01 $121 - $160	-16 Reduced 59.26%	11 $0
Q2 2021 Aug 13, 2021	SELL	$6.61 - $10.68 $2,088 - $3,374	-316 Reduced 92.13%	27 $0
Q1 2021 May 12, 2021	BUY	$6.65 - $8.93 $405 - $544	61 Added 21.63%	343 $2,000
Q4 2020 Feb 11, 2021	BUY	$5.86 - $8.58 $1,588 - $2,325	271 Added 2463.64%	282 $2,000
Q3 2020 Nov 12, 2020	SELL	$5.58 - $8.45 $55 - $84	-10 Reduced 47.62%	11 $0
Q2 2020 Jul 31, 2020	SELL	$6.15 - $9.35 $2,896 - $4,403	-471 Reduced 95.73%	21 $0
Q1 2020 May 01, 2020	SELL	$5.99 - $10.29 $658 - $1,131	-110 Reduced 18.27%	492 $3,000
Q4 2019 Feb 14, 2020	BUY	$7.91 - $11.35 $4,595 - $6,594	581 Added 2766.67%	602 $6,000
Q3 2019 Nov 14, 2019	BUY	$5.0 - $8.9 $105 - $186	21 New	21 $0

Others Institutions Holding NEPH

# of Institutions

Shares Held

4.26M

Call Options Held

Put Options Held

View Full List

About NEPHROS INC

Ticker NEPH
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 10,318,800
Market Cap $21.8M
Description
Nephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United States. The company operates in three segments: Water Filtration, Pathogen Detection, and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water ...

More about NEPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account